Dyschromatosis universalis hereditaria

From WikiMD.com Medical Encyclopedia

A rare genetic skin disorder








Classification
External resources



Dyschromatosis universalis hereditaria (DUH) is a rare genetic disorder characterized by a mixture of hyperpigmented and hypopigmented macules distributed over the body. It is an autosomal dominant condition, although autosomal recessive forms have also been reported.

Presentation[edit | edit source]

Individuals with dyschromatosis universalis hereditaria typically present with a mottled appearance of the skin due to the presence of both hyperpigmented and hypopigmented macules. These macules are usually distributed symmetrically across the body, including the trunk, limbs, and sometimes the face. The condition often becomes apparent in infancy or early childhood and tends to progress with age.

Genetics[edit | edit source]

DUH is primarily inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. However, some cases have been linked to autosomal recessive inheritance. Mutations in the ABCB6 gene have been associated with the condition, although the exact pathophysiological mechanisms remain unclear.

Pathophysiology[edit | edit source]

The pathophysiology of dyschromatosis universalis hereditaria involves abnormalities in the melanin production or distribution within the skin. The presence of both hyperpigmented and hypopigmented areas suggests a defect in the regulation of melanocyte function or melanin synthesis. The specific molecular pathways disrupted in DUH are still under investigation.

Diagnosis[edit | edit source]

The diagnosis of DUH is primarily clinical, based on the characteristic appearance of the skin. A detailed family history can aid in identifying the hereditary nature of the condition. Genetic testing may be used to confirm the diagnosis and identify mutations in the ABCB6 gene or other associated genes.

Management[edit | edit source]

There is currently no cure for dyschromatosis universalis hereditaria. Management focuses on cosmetic concerns and may include the use of cosmetic camouflage to even out skin tone. Patients should be monitored for any potential complications, although the condition is generally benign and does not affect overall health.

Prognosis[edit | edit source]

The prognosis for individuals with DUH is generally good, as the condition is primarily cosmetic and does not typically lead to other health issues. However, the psychological impact of the skin changes can be significant, and supportive care may be beneficial.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD